The game-changing research for diabetes treatment

Currently, if you’re diagnosed with diabetes, you’ll be given a ‘one-size-fits-all’ treatment, which isn’t necessarily the best way to manage such a complex disease.

However, genomic research offers the possibility of more targeted, personalised, precision treatments that promise better patient outcomes.

This can’t come too soon. With rates soaring, there’s an urgent need to find new therapeutics that can treat all forms of diabetes more effectively.

Michael Higgins is Clinical Programme Manager at research company, Genomics Medicine Ireland (GMI), which was established in 2015 with the aim of building a world-class disease specific genomic database.

This will include data from 400,000 volunteers in Ireland from both ‘healthy’ participants and patients with up to 60 different diseases (including diabetes). This is one of the largest genomics studies in the world.

Understanding diabetes and identifying new drugs

“Genomics is the large scale study of all our genes and their functions,” he explains. “Our genes contain sequences of DNA in our cells that act as the blueprint for every human being, controlling everything from our eye and hair colour to our likelihood of developing a particular disease.

Read full article at